ONCODEA
DEAD

Serial Number

97249635

Owner

Oncodea Corporation

Attorney

Daniel A. Rosenberg

First Use Date

Dec 1, 2024

Filing Date

Feb 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ONCODEA Trademark

Serial Number: 97249635

ONCODEA is a trademark filed by Oncodea Corporation on February 2, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Oncodea Corporation (4 trademarks)

1000 Westgate Dr. #1002
St. Paul, MN 55114

Entity Type: 03

Trademark Details

Filing Date

February 2, 2022

Registration Date

Not Registered

First Use Anywhere

December 1, 2024

First Use in Commerce

December 1, 2024

Published for Opposition

April 9, 2024

Goods & Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals; medical diagnostic testing, monitoring and reporting services; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories featuring software-based and laboratory-based analysis of blood samples for detection of cancer

Scientific and technological services and research and design relating thereto, namely, medical and scientific research in the field of cancer treatment and diagnosis; industrial engineering analysis and industrial research services in the field of cancer treatment and diagnosis; design and development of computer hardware and non-downloadable software; providing medical testing services and information in the field of cancer research and disease classification; providing temporary use of on-line non-downloadable software and applications for use in medical testing, namely, software using artificial intelligence for machine learning to detect the presence of multiple cancers and other diseases; providing temporary use of on-line non-downloadable computer software for the processing and analysis of data relating to the detection of multiple cancers and other diseases; providing laboratory research services in the field of gene expression, namely, cancer biology; application service provider (ASP) featuring software using artificial intelligence for machine learning and laboratory based analysis of blood samples for detection of multiple cancers and other diseases

Scientific apparatus and instruments for measuring relative DNA, RNA, carbohydrate, lipid, and protein and parts and fittings therefor; medical laboratory research instruments for detecting molecular indicators of multiple cancers and other diseases; downloadable computer software for diagnosing cancer using artificial intelligence and machine learning technology; blank digital storage media; blank analogue recording and storage media in the nature of blank audio and video tapes; mechanisms for coin operated apparatus; cash registers; calculators; computers and computer peripheral devices; diving suits; divers' masks; ear plugs for divers; nose clips for divers and swimmers; gloves for divers; breathing apparatus for underwater swimming; fire extinguishing apparatus; downloadable computer software for controlling and managing patient medical information; downloadable computer software for the early detection and diagnosis of multiple cancers and other diseases

Medical diagnostic apparatus for testing DNA, RNA, carbohydrates, lipids, proteins, and other metabolites incorporating recorded software for the early detection and diagnosis of multiple cancers and other diseases; diagnostic apparatus for the detection of cancer, namely, for early detection and diagnosis of multiple cancers

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 17, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 17, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 29, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 29, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 4, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 4, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
May 4, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 15, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 15, 2025 AITU
USE AMENDMENT FILED
Dec 4, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 4, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 4, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 5, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 5, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 5, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 5, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 12, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 12, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 12, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2023 CRFA
ASSIGNED TO LIE
Dec 7, 2023 ALIE
ASSIGNED TO EXAMINER
Oct 5, 2023 DOCK
NOTICE OF REVIVAL - E-MAILED
Jul 7, 2023 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2023 TROA
PETITION TO REVIVE-GRANTED
Jul 7, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 7, 2023 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 15, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 15, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 15, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 22, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 14, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 9, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2022 NWOS